Dr. Anitha Sara Mathew-Shaji, DO

Dr. Mathew-Shaji practices at Northwell Health Physician Partners Cardiology in Roslyn Heights, New York.

Dr. Mathew-Shaji's NPI, 1003049867, was assigned on August 27, 2009. Dr. Mathew-Shaji holds New York license 266066.

Dr. Mathew-Shaji's primary practice is Northwell Health Physician Partners Cardiology, at 70 Glen Cove Rd, Roslyn Heights, NY 11577 in Nassau County. The practice phone is (516) 321-7400.

Dr. Mathew-Shaji's primary practice is Northwell Health Physician Partners Cardiology in Roslyn Heights, New York. Dr. Mathew-Shaji is also affiliated with North Shore University Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Mathew-Shaji to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mathew-Shaji practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Mathew-Shaji's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Mathew-Shaji is board certified in internal medicine by the American Board of Internal Medicine. Dr. Mathew-Shaji is licensed in New York.

CMS data shows 523 Medicare services from Dr. Mathew-Shaji across 8 procedure codes in 2024, for 151 Medicare patients. Medicare paid $28,651 for them. Every service was in an office.

CMS counts 151 Medicare patients who saw Dr. Mathew-Shaji in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mathew-Shaji's median patient age at 53, with 67% women.

In 2024, Dr. Mathew-Shaji wrote 1,806 Medicare Part D claims for 288 patients. 88% of them were for generic drugs. CMS names the drug for 1,267 of them, across 37 drugs with 11 or more claims each, at $80,885 in total drug cost. In 2023, CMS named 1,169 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Mathew-Shaji for performance year 2024, reported through an alternative payment model (APM). Dr. Mathew-Shaji accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mathew-Shaji as offering telehealth.

Dmand AI links Dr. Mathew-Shaji to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.